Thanks, I didn't see any list posted earlier.
Still seems like a bit of a storm in a tea cup, given the discrepancies have only been produced by testing to EU standards that did not actually apply to the products in the regions they were manufactured in, or even the region the tests were being done in (HK).
You could argue that everyone should apply the most stringent standards that exist anywhere in the world, but if the difference in risk between EU and NZ approved levels of glycidyl is negligible then it is probably not really much of a concern.
EDIT: Oh I see you subsequent post - no cause for concern either way then.
- Forums
- ASX - By Stock
- A2M
- Actual Report Headline from Consumer Council
Actual Report Headline from Consumer Council, page-6
-
-
- There are more pages in this discussion • 38 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add A2M (ASX) to my watchlist
(20min delay)
|
|||||
Last
$6.37 |
Change
0.140(2.25%) |
Mkt cap ! $4.612B |
Open | High | Low | Value | Volume |
$6.24 | $6.40 | $6.23 | $6.204M | 979.3K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 3066 | $6.37 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$6.39 | 8962 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 3066 | 6.370 |
7 | 30512 | 6.360 |
2 | 22216 | 6.350 |
1 | 8221 | 6.340 |
2 | 8721 | 6.330 |
Price($) | Vol. | No. |
---|---|---|
6.390 | 8962 | 2 |
6.400 | 23681 | 11 |
6.410 | 5156 | 2 |
6.420 | 12175 | 3 |
6.430 | 8921 | 2 |
Last trade - 16.10pm 07/10/2024 (20 minute delay) ? |
Featured News
A2M (ASX) Chart |